Latest news
Loading news…
ABSCINT is a clinical stage molecular imaging company developing in-vivo diagnostics based on single domain antibodies.
Abscint on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.
Abscint was acquired by Curium in 2026.
Funding Rounds
1
Last Funding
Acquisitions
0
Monthly Visits
Contacts
2
About Abscint
Funding & Financials
- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Ganshoren, Brussels Hoofdstedelijk Gewest, Belgium
Abscint Funding Rounds
1 results
Upgrade to Pro to view this datasetUpgrade
| Organization Name | Funding Type | Lead Investor Names | Org Hq Country | ||
|---|---|---|---|---|---|
1–1 of 1Show
Page 1 / 1
2
professional contacts at Abscint
Contact execs at Abscint →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Bulk Dataset Export
Need the data in bulk? Buy the entire dataset.
5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools
Delivered as CSV, JSON or Parquet — at startup-friendly pricing.
Recent News related to Abscint
Loading news…
FAQs about Abscint
People who checked this page also checked these
Browse the full Acquirezy directory.